C
Counsyl
Biotech & Life Sciences · San Francisco, United States · Founded 2007
DNA screening and genetic counseling for diseases that can impact men, women & their children. Counsyl is the US leader in ECS MoreLess
Myriad Women's Health, formerly known as Counsyl, specializes in genetic testing services aimed at reproductive health. The company operates in the healthcare sector, focusing on providing genetic screening and counseling services to individuals planning a pregnancy or concerned about their reproductive health. Myriad Women's Health serves a diverse range of clients, including patients, healthcare providers, and telehealth platforms. The business model revolves around offering genetic tests that can be ordered online or through healthcare providers, followed by detailed counseling sessions to interpret the results. Revenue is generated through the sale of these genetic tests and associated counseling services. The company leverages telehealth to make genetic testing more accessible, especially in the post-COVID-19 world, where remote healthcare solutions are increasingly in demand.
Keywords: genetic testing, reproductive health, telehealth, personalized care, healthcare, genetic counseling, telemedicine, patient education, remote solutions, reproductive risk.
Company overview
Counsyl company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2007
- Headquarters
- San Francisco, United States
- Employees
- 47
- Open positions
- None listed
- Dealroom signal
- 69.8
Valuation & funding
Counsyl funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | May 2018 | $375M | — | Myriad Genetics | — |
| FundingOther financing | Nov 2017 | $80M | — | Goldman Sachs · Felicis · Pilot Growth Equity · Founders Fund | — |
| SERIES DOther financing | May 2014 | $28M | $112M | Goldman Sachs · Rosemont Seneca Partners | — |
| SERIES COther financing | Aug 2012 | $7.5M | $30M | Felicis | — |
| GROWTH EQUITY VCOther financing | Dec 2011 | $54M | — | Pilot Growth Equity · Founders Fund | — |
| SERIES AOther financing | Jun 2010 | Undisclosed | — | ||
| EARLY VCOther financing | Apr 2010 | Undisclosed | — | ||
| EARLY VCOther financing | Mar 2010 | Undisclosed | — |
Growth signals
Counsyl website traffic
Latest recorded traffic for Counsyl is 81K monthly website visits, down 15.6% over the last three months. Counsyl's team declined 27.7% over the past year.
Comparisons
Counsyl compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Counsyl's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Counsyl has talent and traffic
In the news
Latest news about Counsyl
Recent press, funding announcements, and product moves mentioning Counsyl — open to read from the original sources.
Market sentiment
What the market is saying about Counsyl
An AI-synthesized read of the highest-engagement posts about Counsyl on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Counsyl’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.